Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Benn

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Brain : a Journal of Neurology|June 13, 2015
A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch developmentMichael S Nahorski, Lihadh Al-Gazali, Jozef Hertecant, et al.
Brain : a Journal of Neurology|February 22, 2024
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's diseaseSarah G Aldous, Edward J Smith, Christian Landles, et al.
Human Molecular Genetics|September 27, 2005
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's diseaseCaroline L Benn, Christian Landles, He Li, et al.
Brain Communications|September 21, 2020
Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease ModelChristian Landles, Rebecca E Milton, Nadira Ali, et al.
The Journal of Experimental Medicine|July 16, 2008
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseMaria Björkqvist, Edward J Wild, Jenny Thiele, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2022
Oleic acid is an endogenous ligand of TLX/NR2E1 that triggers hippocampal neurogenesisPrasanna Kandel, Fatih Semerci, Rachana Mishra, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cellsDalia Barsyte-Lovejoy, Fengling Li, Menno J Oudhoff, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Brain : a Journal of Neurology|June 13, 2015
A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch developmentMichael S Nahorski, Lihadh Al-Gazali, Jozef Hertecant, et al.
Brain : a Journal of Neurology|February 22, 2024
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's diseaseSarah G Aldous, Edward J Smith, Christian Landles, et al.
Human Molecular Genetics|September 27, 2005
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's diseaseCaroline L Benn, Christian Landles, He Li, et al.
Brain Communications|September 21, 2020
Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease ModelChristian Landles, Rebecca E Milton, Nadira Ali, et al.
The Journal of Experimental Medicine|July 16, 2008
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseMaria Björkqvist, Edward J Wild, Jenny Thiele, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2022
Oleic acid is an endogenous ligand of TLX/NR2E1 that triggers hippocampal neurogenesisPrasanna Kandel, Fatih Semerci, Rachana Mishra, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cellsDalia Barsyte-Lovejoy, Fengling Li, Menno J Oudhoff, et al.
Pageof 5